Skip to the page

Data / Drug companies / Losartan potassium and hydrochlorothiazide

Losartan potassium and hydrochlorothiazide: 31 companies and 111 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Losartan potassium and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 31 companies, with 111 products in commercial distribution. 108 of the products (97.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on May 27, 2026.

The request: Get every company that lists losartan potassium and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
31
Products
111
Generic (ANDA) products
108 (97.3%)
Application numbers
11
Routes
Oral
Brand names
Hyzaar
openFDA record search
api.fda.gov

Companies that list losartan potassium and hydrochlorothiazide

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions15tablet, film coated; tabletGeneric drugs (ANDA)September 4, 2024
Direct_Rx12tablet, film coated; tabletGeneric drugs (ANDA)February 21, 2022
Bryant Ranch Prepack8tablet, film coated; tabletGeneric drugs (ANDA)February 15, 2018
Proficient Rx LP7tablet, film coatedGeneric drugs (ANDA)May 23, 2016
Bryant Ranch Prepack6tablet, film coatedGeneric drugs (ANDA)May 14, 2025
Remedyrepack Inc.4tablet, film coatedGeneric drugs (ANDA)May 16, 2022
Alembic Pharmaceuticals Inc.3tablet, film coatedGeneric drugs (ANDA)May 23, 2016
Alembic Pharmaceuticals Limited3tablet, film coatedGeneric drugs (ANDA)May 23, 2016
Aurobindo Pharma Limited3tablet, film coatedGeneric drugs (ANDA)October 6, 2010
AvKARE3tablet, film coatedGeneric drugs (ANDA)August 31, 2022
Camber Pharmaceuticals, Inc.3tablet, film coatedGeneric drugs (ANDA)May 27, 2026
Granules Pharmaceuticals Inc.3tablet, film coatedGeneric drugs (ANDA)September 29, 2023
Jubilant Cadista Pharmaceuticals Inc.3tablet, film coatedGeneric drugs (ANDA)October 30, 2012
Lupin Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)October 6, 2010
Macleods Pharmaceuticals Limited3tablet, film coatedGeneric drugs (ANDA)September 10, 2012
NorthStar Rx LLC3tablet, film coatedGeneric drugs (ANDA)September 4, 2024
Organon LLC3tablet, film coatedNew drug applications (NDA)June 1, 2021
Preferred Pharmaceuticals Inc.3tablet, film coated; tabletGeneric drugs (ANDA)April 15, 2024
Solco Healthcare US, LLC3tablet, film coatedGeneric drugs (ANDA)February 15, 2018
Teva Pharmaceuticals USA, Inc.3tablet, film coatedGeneric drugs (ANDA)April 6, 2010
Unichem Pharmaceuticals (USA), Inc.3tablet, film coatedGeneric drugs (ANDA)July 21, 2017
Bryant Ranch Prepack2tablet, film coatedGeneric drugs (ANDA)October 30, 2012
NuCare Pharmaceuticals,Inc.2tablet, film coatedGeneric drugs (ANDA)May 23, 2016
Proficient Rx LP2tablet, film coatedGeneric drugs (ANDA)February 15, 2018
QPharma, Inc.2tablet, film coatedGeneric drugs (ANDA)February 15, 2018
Aphena Pharma Solutions - Tennessee, LLC1tablet, film coatedGeneric drugs (ANDA)July 21, 2017
Coupler LLC1tablet, film coatedGeneric drugs (ANDA)December 2, 2025
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)October 30, 2012
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)October 6, 2010
Quality Care Products, LLC1tablet, film coatedGeneric drugs (ANDA)August 28, 2024
St. Mary's Medical Park Pharmacy1tablet, film coatedGeneric drugs (ANDA)September 30, 2022

Dosage forms

Dosage formProductsShare
Tablet, film coated10392.8%
Tablet87.2%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)10897.3%
New drug applications (NDA)32.7%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.